T-cell recognition of peptides bound to MHC class II (MHCII) molecules is a central event in cell-mediated adaptive immunity. The current paradigm holds that prebound class II-associated invariant chain peptides (CLIP) and all subsequent antigens maintain a canonical orientation in the MHCII binding groove. Here we provide evidence for MHCII-bound CLIP inversion. NMR spectroscopy demonstrates that the interconversion from the canonical to the inverse alignment is a dynamic process, and X-ray crystallography shows that conserved MHC residues form a hydrogen bond network with the peptide backbone in both orientations. The natural catalyst HLA-DM accelerates peptide reorientation and the exchange of either canonically or inversely bound CLIP against antigenic peptide. Thus, noncanonical MHC-CLIP displays the hallmarks of a structurally and functionally intact antigen-presenting complex.
T-cell recognition of peptides bound to MHC class II (MHCII) molecules is a central event in cell-mediated adaptive immunity. The current paradigm holds that prebound class II-associated invariant chain peptides (CLIP) and all subsequent antigens maintain a canonical orientation in the MHCII binding groove. Here we provide evidence for MHCII-bound CLIP inversion. NMR spectroscopy demonstrates that the interconversion from the canonical to the inverse alignment is a dynamic process, and X-ray crystallography shows that conserved MHC residues form a hydrogen bond network with the peptide backbone in both orientations. The natural catalyst HLA-DM accelerates peptide reorientation and the exchange of either canonically or inversely bound CLIP against antigenic peptide. Thus, noncanonical MHC-CLIP displays the hallmarks of a structurally and functionally intact antigen-presenting complex.
bidirectional binding | antigen presentation | peptide loading I mmune responses against extracellular pathogens rely on antigen presentation by MHC class II (MHCII) molecules (1) . After endocytosis, exogenous proteins are proteolytically degraded in endolysosomal vesicles that also harbor MHCII molecules, which at this point are bound to self-peptides originating from the invariant chain protein. HLA-DM catalyzed exchange of class II-associated invariant chain peptides (CLIP) for pathogenderived peptides of higher affinity then leads to the formation and surface presentation of immunogenic MHCII-peptide complexes (2) . However, evidence is mounting that CLIP function extends beyond its placeholder properties: stable MHCII-CLIP complexes are up-regulated on dendritic cells upon maturation and modulate the activation of T cells specific for exogenous foreign antigen (3) . The continued presentation of CLIP on the surface of antigen presenting cells requires the active maintenance of peripheral tolerance against self (4) . MHC alleles susceptible to autoimmune diseases, in contrast, are associated with low affinities for, and thus low surface levels of, CLIP (5) . Taken together, the presence of the self-peptide CLIP on the cell surface seems to shape the T-cell repertoire in vivo, which, as observed for other peptides as well, has additionally been shown to be influenced by N-terminal length variations (6, 7) .
The MHCII-peptide binding mode might account for these observations. Peptides are assumed to bind in a conserved N-to C-terminal orientation by two governing principles: (i) a set of hydrogen bonds between the peptide backbone and MHC side chains; and (ii) the geometrically and chemically favorable accommodation of four to five peptide side chains by defined MHC surface pockets (8) . The observation that single peptide-MHC complexes can elicit functionally distinct immune responses has been attributed to distinct peptide binding registers (9, 10) or the existence of different conformational isomers of the MHCII itself (11, 12) . However, because X-ray crystallography might not capture the dynamic rearrangements that accompany alternative complex formation, the molecular basis for these findings is still poorly understood.
Here we determined the crystal structures of the human MHCII molecule HLA-DR1 in complex with two CLIP length variants and observed a unique bidirectional binding mode. NMR analyses by chemical shift mapping and spin label-induced relaxation enhancement of the uncatalyzed and HLA-DM edited reactions illustrate the dynamic reorientation of the complex in solution. Surface charge distributions differ largely for the two MHC-CLIP variants and result in T-cell epitopes with inverted polarity.
Results
Crystal Structures of HLA-DR1/CLIP Reveal Bidirectional Binding. We determined the crystal structures of the human MHCII molecule HLA-DR1 in complex with the two CLIP length variants CLIP 106-120 and CLIP 102-120 (see Fig. 1A for sequences; numbering refers to the p35 form of invariant chain-see Methods for details). The latter exhibited a canonical peptide alignment showing all of the hallmarks of a conventional MHC-peptide complex [Figs. 1B (Right) and C, and 2A; Table S1 ]: the pocket P 1 of the MHC molecule is occupied by the first anchor residue near the N terminus of the peptide, and side chains 4, 6, and 9 protrude into the corresponding surface depressions of the MHC binding groove. In contrast, the short CLIP variant was found to bind in an inverse orientation, with the C-terminal methionine accommodated in P 1 and the N-terminal methionine in P 9 [ Fig. 1B (Left) and C, and Table S1 ]. Whereas co-refolded HLA-DR1/CLIP 102-120 crystallized at room temperature, crystals showing the inverted orientation only grew at the same temperature when HLA-DR1 was refolded without any peptide and subsequently loaded with CLIP 106-120 . However, when changing the conditions to refolding HLA-DR1 in the presence of CLIP 106-120 and crystallizing the complex at low temperatures (SI Materials and Methods) we could additionally determine the structure of canonically aligned CLIP 106-120 bound to the MHC (Fig. S1) .
In-depth comparison of the three structures analyzed here reveals as a striking feature the preservation of a dense hydrogen bond network in both orientations (Fig. S2A ). This particular feature of peptide-MHC complexes is mediated by MHC side chains that interact with the peptide backbone and, hence, is peptide-sequence independent. Surprisingly, almost no rearrangement of MHC side chains is necessary to preserve the network in the inverted orientation, and the pseudosymmetry of the polyproline type II helix ensures the availability of CO and NH peptide backAuthor contributions: S.G., A.S., J.S., O.R., and C.F. designed research; S.G., A.S., J.S., and Y.R. performed research; S.G., A.S., J.S., Y.R., U.H., K.-H.W., G.J., K.F., O.R., and C.F. analyzed data; and S.G., A.S., J.S., and C.F. wrote the paper. Table S2 ). In the reverse peptide orientation an additional H-bond between the side chain carbonyl group of αN62 and the backbone NH group of P 5 of the peptide can be formed ( Fig. 2A and Fig.  S2A ). The central threonine at P 5 acts as point of symmetry, with methionine occupying P 1 and P 9 and promiscuous binding of either alanine or proline at positions P 4 and P 6 ( Fig. 1 A and C) .
A likely explanation for the observed peptide inversion is revealed by a closer analysis of the hydrogen bond network around P −2 of the MHC. At this position CLIP 102-120 is engaged in three hydrogen bonds with the MHCII residues αF51 and αS53. In the canonical HLA-DR1/CLIP 106-120 complex this stabilizing interface is missing. However, upon peptide inversion these hydrogen bonds are reestablished (Fig. 2) . Interestingly, the only other available MHCII-CLIP structures are of longer CLIP variants that are able to form these critical N-terminal hydrogen bonds and display a canonical peptide orientation (13, 14) .
Peptide Inversion Monitored by NMR Chemical Shift Analysis of HLA-DR1/CLIP 106-120 . To ensure that bidirectional peptide alignment is not due to constraints imposed by the crystallization process, analysis of MHC-ligand complexes was carried out in solution. The only spectroscopic method to yield such information at the atomic level is NMR. Using an optimized refolding procedure Upper: Lateral cut of the binding groove of HLA-DR1 (peptide removed), highlighting the antigen-binding pockets P 1 and P 9 . Lower: 2F o -F c electron density maps (contoured at 1σ) of peptides derived from the crystal structure of HLA-DR1/CLIP 106-120,flipped and HLA-DR1/CLIP 102-120 are shown from the same perspective inside the binding groove. Both peptides appear with two methionine side chains sequestered into the respective P 1 and P 9 pockets, as indicated.
(15), we obtained NMR spectra of high quality for several HLA-DR1/peptide complexes ( Fig. S3 A and B) and assigned the backbone chemical shifts for the 15 
Interestingly, NMR spectra obtained from 15 N-β-chain-labeled MHC molecules co-refolded with CLIP 106-120 showed chemical shift changes over time that exclusively map to the peptidebinding β1 domain (Fig. S3 B and C) . The initial spectrum superimposed well with that obtained from the CLIP 102-120 complex, indicating that both assemblies indeed represent the same canonical binding mode observed in the crystal structures of MHC refolded in the presence of peptide (Fig. S3A) . Realignment of the peptide is then paralleled by time-dependent changes observed in the NMR spectra (Fig. S3B) . Large NH backbone chemical shift differences (Fig. S3C ) map to residues in the peptide binding groove, as for example βY78 and βH81, which experience a different chemical environment in the presence of canonical or flipped CLIP, as is seen in the corresponding crystal structures (Fig. 3) . Thus, this thermodynamically slightly more stable complex (Table S3 ) is suggested to be identical with the crystallized inverted complex obtained from HLA-DR1 refolded in isolation and loaded with CLIP 106-120 a posteriori. In support, the NMR spectra of the latter assembly and the equilibrated corefolded sample are fully superimposable (Fig. S4) .
Spin-Labeled CLIP 106-120 Confirms the Inverted Orientation. The chemical shift analysis is in full agreement with peptide inversion relative to the MHC binding groove, yet it only provides circumstantial evidence. To provide more direct confirmation of the noncanonical binding mode in solution, we performed NMR experiments with CLIP 106-120 carrying an N-terminally attached TEMPO (2,2,6,6-tetramethylpiperidine-1-oxyl) moiety (Fig. 4A) . Atoms up to a distance of 15-20 Å of the unpaired electron should experience enhanced relaxation leading to a clearly increased line-width of the corresponding NMR resonances. Therefore, the TEMPO group should affect residues of the MHC molecule that accommodate the N-terminal methionine of the peptide. TEMPO-CLIP 106-120 was loaded a posteriori to directly obtain the thermodynamically preferred complex. We observed dramatic changes in NMR signal intensities for a single contiguous region within the MHC molecule ( Fig. 4B and C) , comprising residues β54-68 that surround the P 9 pocket of the antigen binding site (Fig. 4D) . We conclude that the thermodynamically stable MHCII-CLIP 106-120 complex detected in solution contains a peptide in the reverse orientation corresponding to the crystal structure shown in Fig. 1B (Left) .
HLA-DM-Catalyzed Peptide Inversion and Exchange Observed by NMR. CLIP inversion from the kinetically trapped to the thermodynamically more stable complex proceeds over a period of days at 37°C, with a half-maximum inversion after ≈40 ± 6 h. We have to assume that CLIP cleaved from the invariant chain in the late endosome corresponds to the kinetically trapped variant found in our solution NMR studies (16) . Peptide inversion would 14 Nα/ 15 Nβ)/CLIP 106-120 reflect the peptide flipping sensed by these two amino acids. The blue spectrum was measured directly after sample preparation by corefolding, whereas the red one was recorded from the same sample after 120 h at 37°C.
then not occur in a physiologically relevant time frame. In vivo, however, peptide exchange is enhanced by the natural catalyst HLA-DM. It was therefore important to determine whether CLIP inversion could also be catalyzed. To further investigate this phenomenon, we capitalized on the finding that peptide reorientation was observed for the HLA-DR1/CLIP 102-120 complex as well. This process was extremely slow and came to a halt at 50% inversion, indicating the same thermodynamic stability for both peptide alignments (Fig. S5 and Table S3 ). However, when adding equimolar amounts of purified HLA-DM to freshly refolded HLA-DR1 complexed with CLIP 102-120 , it catalyzed the 50% exchange within the experimental dead time of 30 min (Fig. 5A) . We next asked whether both CLIP orientations would allow efficient exchange to a more tightly binding antigen. The influenza hemagglutinin-derived peptide (HA 306-318 ) was added in excess to inverted HLA-DR1/CLIP 106-120 or canonically bound HLA-DR1/ CLIP 102-120 in the presence of HLA-DM (Fig. 5B) . Exchange was rapid for both samples, and the resultant spectra were fully superimposable. Therefore, as illustrated in the scheme in Fig. S6A , HLA-DM catalyzes both flipping of CLIP and, independent of the CLIP orientation, exchange against HA.
Discussion
Although an imposing number of peptide-MHC complexes have been successfully crystallized for both MHC classes, investigation of MHCs in solution remains a great challenge. Some information could be obtained on MHCII complexes by detecting the bound peptide (17, 18) . NMR analysis of the MHC protein itself was only possible for the MHCI-β 2 -microglobulin (19-21), a murine single-chain construct of an MHCI heavy chain fragment (22) , and a fragment of a murine class II MHC (23) . In this study we use backbone NMR assignment of an MHCII subunit to investigate the dynamic reorientation of CLIP variants in complex with HLA-DR1. Complementary, the crystal structures of three HLA-DR1/CLIP complexes delineate the structural requirements for bidirectional binding. They show that the N-terminally shortened CLIP 106-120 variant in its canonical orientation lacks hydrogen bonds formed by the P −2 residue in the longer CLIP 102-120 peptide. Peptide inversion of CLIP 106-120 reinstalls these hydrogen bonds and likely drives reorientation. CLIP 106-120 shows complete realignment, and even the longer CLIP 102-120 still leads to ≈50% inversion. In this case, the N-terminal hydrogen bonds can be formed in both orientations. Hence, hydrogen bonding and pocket accommodation for residues P 1 to P 9 is equally favorable in both alignments.
Our observations show that there are no general restrictions for inverted binding of peptides to MHCII. The pseudosymmetry of CLIP might facilitate a bidirectional binding mode, but it is unlikely that the promiscuous binding pockets of MHCII are incompatible with the flipped orientation in any of the thousands of peptides that are amenable to MHCII loading within the cell. Although inversely bound peptides might be the exception, we have to note that roughly half of the crystallized unique MHCIIpeptide complexes were obtained from single-chain constructs where the peptide is tethered to the N terminus of the β-chain, which is incompatible with a reversed orientation. The observation that MHCII epitope prediction algorithms, which assume a canonical binding mode, are currently significantly less reliable than those for MHCI (24, 25) N-HSQC spectra were plotted to the HLA-DRβ sequence. P indicates a proline invisible in the HSQC spectrum, and asterisks mark missing assignments. (D) Epitope mapping of residues that show significantly reduced HSQC-peak intensities according to C.
Spin-label-affected β-chain residues 39, 47, 49, 54-68, and 75 are marked in red in the crystal structure of HLA-DR1/CLIP 106-120 (peptide not included for clarity).
molecules allows for orientational promiscuity, we do not expect MHCI molecules to show the same behavior. For MHCI complexes the charged termini of the peptide are counterbalanced by charged MHC residues, thereby strongly favoring peptide binding in a canonical orientation.
In the cell the preference for one CLIP orientation should be modulated by anchoring residues as well as the presence of the P −2 residue, which is influenced by the action of proteases in the endolysosomal compartment (26) . Additionally, formation of the thermodynamically stable complex will depend on the activity and hence the cell type-specific regulation of HLA-DM. For example, in a B lymphoblastoid cell line deficient for HLA-DM, CLIP 106-120 was the most prominent invariant chain fragment presented by HLA-DR1 (27) . Moreover, a short CLIP 106-121 variant in complex with HLA-DR1 could be detected by mass spectrometry at the surface of dendritic cells upon maturation, coinciding with the down-regulation of HLA-DM (3). In these cases the formation and surface preservation of the kinetically trapped canonically bound CLIP is probable, whereas antigenpresenting cells with high HLA-DM activity should favor the formation of inverted MHCII-CLIP. These complexes are likely to be presented on the cell surface, particularly if no higheraffinity antigen is available for MHC alleles forming stable CLIP complexes (as for example HLA-DR1). Assuming thatdepending on MHC/CLIP affinity, protease, and HLA-DM activity-CLIP bound in both orientations reach the cell surface, what would be the immunological consequence? The generalized structural hallmarks for the formation of the trimeric MHCpeptide-T cell receptor (TCR) complex indicate the interactions for the encountering TCR to center around the middle of the MHC-bound peptide (28, 29) . Although a certain variability in this docking mode has been observed for autoimmunogenic peptide-MHC complexes (30) (31) (32) , the surface charge reversal of the two CLIP orientational variants (Fig. S6B ) would likely engage different TCRs. Moreover, assuming that differential Nterminal processing occurs for self-peptides other than CLIP, it will be of interest to probe likely candidate peptides for bidirectional binding to MHCII alleles. Such a finding would be of biological relevance if there is an orientational difference between presentation of a particular self-peptide in the thymus during positive and negative selection of T cells and later in the periphery. In this case, T cells could recognize the self-peptide as foreign and could contribute to the antigenic component of autoimmune phenomena. As a first step toward such a model, future research has to show that inverted MHCII-peptide complexes reach the surface of the cell and thereby invoke physiologically relevant T-cell responses.
Materials and Methods
Expression and Purification of Proteins. Recombinant bacterial HLA-DR1 was produced and refolded in milligram amounts as described previously (15, 33) . HLA-DM was produced in stably transfected Schneider cells as previously described (2) . Details of the purification protocol can be found in SI Materials and Methods.
Crystallization of HLA-DR1 with Variants of CLIP. All HLA-DR1/CLIP samples were either produced by co-refolding HLA-DR1 and peptide or by posterior loading with subsequent gel filtration. Samples were concentrated to 10 mg/ mL before being subjected to crystallization. X-ray diffraction data were collected at 100 K on beamline BL14.1 at the BESSY synchrotron (Berlin, Germany). Additional information is available in SI Materials and Methods.
High-Field NMR Spectroscopy of MHCII Molecules. NMR spectra were acquired on Bruker AV700 MHz or 900 MHz Avance spectrometers equipped with triple-resonance cryoprobes. To decrease spectral complexity only the DRβ subunit was labeled with 15 N. For assignment of the DRβ backbone resonances, we acquired standard 3D experiments with Peptides, Loading of MHC, and Peptide Exchange by HLA-DM. Peptides were synthesized using Fmoc-based solid phase chemistry. They were used for loading in 10-fold molar excess during protein refolding and 10-to 20-fold molar excess for loading a posteriori in the presence of the dipeptidic MHC loading enhancer Ac-FR-NH 2 to accelerate the reaction (34) . To exchange CLIP 106-120 or CLIP 102-120 for HA 306-318 , HLA-DM was added to isolated HLA-DR1/CLIP complexes in stoichiometric amounts, followed by addition of HA. CLIP numbering refers to the amino acid sequence of the longer p35 human CLIP variant, as described previously (35) . In regard to the shorter p33 isoform, our peptides refer to sequences 90-104 and 86-104, respectively. ACKNOWLEDGMENTS. We thank Michael Beyermann for standard peptide synthesis; Peter Schmieder for the setup of certain NMR pulse sequences; Ronald Kühne for helpful discussions; and Miriam-Rose Ash for critically reading the manuscript. C.F. was supported by grants from the Bundesministerium für Bildung und Forschung (01 EZ 1010B) and from the Deutsche Forschungsgemeinschaft (SFB765). Nβ)/CLIP 102-120 representing canonical CLIP (blue), HLA-DR1/CLIP 106-120 representing inverted CLIP (red), and spectra of these two samples after HLA-DM-catalyzed exchange against HA 306-318 (light and dark gray, respectively). The latter two spectra superimpose well, indicating the formation of HLA-DR1/HA 306-318 from both HLA-DR1/CLIP complexes.
